MML Investors Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Sell |
|
|||||
|
2025
Q1 | $371K | Sell |
|
|||||
|
2024
Q4 | $496K | Sell |
|
|||||
|
2024
Q3 | $536K | Buy |
|
|||||
|
2024
Q2 | $580K | Sell |
|
|||||
|
2024
Q1 | $727K | Sell |
|
|||||
|
2023
Q4 | $1.23M | Buy |
|
|||||
|
2023
Q3 | $797K | Buy |
|
|||||
|
2023
Q2 | $733K | Buy |
|
|||||
|
2023
Q1 | $625K | Buy |
|
|||||
|
2022
Q4 | $621K | Buy |
|
|||||
|
2022
Q3 | $502K | Buy |
|
|||||
|
2022
Q2 | $477K | Sell |
|
|||||
|
2022
Q1 | $675K | Sell |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $1.02M | Sell |
|
|||||
|
2021
Q2 | $1.12M | Buy |
|
|||||
|
2021
Q1 | $828K | Buy |
|
|||||
|
2020
Q4 | $899K | Sell |
|
|||||
|
2020
Q3 | $799K | Sell |
|
|||||
|
2020
Q2 | $1.44M | Sell |
|
|||||
|
2020
Q1 | $1.06M | Buy |
|
|||||
|
2019
Q4 | $1.03M | Buy |
|
|||||
|
2019
Q3 | $807K | Sell |
|
|||||
|
2019
Q2 | $1.16M | Buy |
|
|||||
|
2019
Q1 | $1.04M | Buy |
|
|||||
|
2018
Q4 | $782K | Buy |
|
|||||
|
2018
Q3 | $748K | Buy |
|
|||||
|
2018
Q2 | $443K | Buy |
|
|||||
|
2018
Q1 | $227K | Buy |
|